Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Feinberg Home > Home > News > 2022 > William Gradishar Receives 2022 Rodger Winn Award from NCCN...

Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental...

Abstract. Purpose: Paclitaxel (PTX) is one the most potent and commonly used chemotherapies for breast and pancreatic cancer. Several ongoing clinical trials are investigating...

A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung...

Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer...

Northwestern Medicine investigators led by Adam Sonabend, MD, recently discovered a protein that confers susceptibility to PTX in breast cancer and...

The protein FOXK2 promotes survival of cancer stem cells in ovarian cancer, according to a Northwestern Medicine study published in the Journal of Clinical...

Join me in honoring cancer survivors, celebrating milestones and advancing life-changing research and cancer care. #LurieCelebrates...

Focus of WorkBioI have been an active clinical investigator vested in the immune-based therapy of melanoma. This has led to my role in the...